MET and cancer: Since miR-221 overexpression and MET pathway activation have been found in many cancers, the authors demonstrated that via both MET- and miR-221- knockdown, there is an increase in levels of tumor suppressor proteins, such as phosphatase and tensin homolog (PTEN).